Table 1.
Circulating leucocyte counts and leucocyte subsets in MRL+/+, MRL/MpJ-faslpr, P-selectin–/– -MRL/MpJ-faslpr, and intercellular adhesion molecule-1 (ICAM-1)–/– -MRL/MpJ-faslpr mice at 8, 16 and 20–25 weeks of age.*
M1/70hi/Gr-1hi | M1/70 hi/Gr-1int | CD3+ | B220+/CD3– | ||
---|---|---|---|---|---|
Total | (PMNs) | (monocyte lineage) | (T cells) | (B cells) | |
MRL+/+ | |||||
8 weeks | 6·8 ± 0·5 (6) | 1·5 ± 0·1 (6) | 0·20 ± 0·28 (6) | 3·2 ± 0·3 (6) | 2·1 ± 0·2 (6) |
16 weeks | 7·4 ± 0·5 (6) | 1·6 ± 0·1 (6) | 0·20 ± 0·01 (6) | 3·2 ± 0·2 (6) | 1·7 ± 0·1 (6) |
20–25 weeks | 4·9 ± 0·6 (7) | 1·3 ± 0·2 (7) | 0·14 ± 0·05 (7) | 1·9 ± 0·2 (7) | 0·9 ± 0·2 (7) |
MRL/MpJ-faslpr | |||||
8 weeks | 5·3 ± 0·4 (6) | 0·9 ± 0·1 (6)† | 0·07 ± 0·01 (6)† | 2·0 ± 0·1 (9)† | 1·0 ± 0·1 (9)† |
16 weeks | 19·4 ± 3·8 (6) | 4·5 ± 0·9 (6)† | 0·77 ± 0·17 (6)† | 12·8 ± 1·3 (6)† | 1·4 ± 0·1 (6) |
20–25 weeks | 29·6 ± 4·1 (7) | 5·3 ± 1·8 (6)† | 0·72 ± 0·18 (6)† | 20·8 ± 1·6 (6)† | 2·0 ± 0·2 (6)† |
P-selectin–/–-MRL/MpJ-faslpr | |||||
8 weeks | 10·9 ± 0·5 (9) | 4·4 ± 0·3 (8)** | 0·56 ± 0·07 (8)** | 3·1 ± 0·4 (6)** | 1·7 ± 0·3 (6)** |
16 weeks | 20·2 ± 4·9 (5) | 5·7 ± 0·7 (6) | 0·79 ± 0·14 (6) | 10·7 ± 0·8 (8) | 2·8 ± 0·2 (8)** |
20–25 weeks | 27·8 ± 4·9 (6) | 6·5 ± 1·6 (6) | 0·72 ± 0·16 (6) | 14·6 ± 1·6 (7)** | 3·1 ± 0·4 (7)** |
ICAM-1–/–-MRL/MpJ-faslpr | |||||
16 weeks | 16·1 ± 4·4 (5) | 3·2 ± 0·8 (6) | 0·50 ± 0·13 (6) | 7·3 ± 0·7 (8)** | 2·0 ± 0·2 (8)** |
20–25 weeks | 28·7 ± 6·7 (5) | 4·3 ± 0·8 (6) | 0·51 ± 0·09 (6) | 18·1 ± 0·8 (6) | 4·7 ± 0·7 (6)** |
Data are expressed as cells × 106/ml ± s.e.m. The number of mice sampled is shown in parentheses.
P < 0·05 versus MRL+/+ at same age.
P < 0·05 versus MRL/MpJ-faslpr at same age.